Personalised Medicine News
The activity of cancer drugs changes depending on the types of microbes living in the gut, according to a UCL-led study into how nematode worms and their microbes process drugs and nutrients.
Published: Apr 20, 2017 5:02:48 PM
The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.
Published: Apr 4, 2017 2:39:27 PM
UCL is involved in the Rosalind Franklin Institute (RFI) – a major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre.
Published: Feb 23, 2017 1:22:00 PM
Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells, finds new UCL-led research funded by the Engineering and Physical Sciences Research Council.
Published: Feb 3, 2017 3:16:25 PM
A new test for bladder cancer could enable GPs to test a urine sample and spare patients the discomfort of a cystoscopy in hospital, according to UCL research published today in Clinical Epigenetics.
Published: Jan 31, 2017 4:50:20 PM
A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.
Published: Dec 20, 2016 9:29:15 AM
Many pain-sensing nerves in the body are thought to respond to all types of ‘painful events’, but new UCL research in mice reveals that in fact most are specialised to respond to specific types such as heat, cold or mechanical pain.
Published: Nov 14, 2016 11:14:30 AM
The risk of developing a psychotic disorder such as schizophrenia is highest for young people, men, ethnic minorities and people living in urban areas and poorer neighbourhoods, finds a new study by UCL and the University of Cambridge.
Published: Oct 24, 2016 5:24:25 PM
Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton.
Published: Oct 6, 2016 4:15:32 PM
A new spin-out company Achilles Therapeutics has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals.
Published: Oct 5, 2016 4:43:56 PM
UCL’s three biomedical research centres (BRCs) have won more
than £167 million in funding from the National Institute for Health Research
(NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more
funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.
Published: Sep 14, 2016 2:58:18 PM
The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.
Published: Sep 1, 2016 10:32:32 AM
An international study involving UCL has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.
Published: Aug 30, 2016 3:34:22 PM
Researchers at UCL and Queen’s University Belfast have discovered that a drug originally developed to treat cardiovascular disease has the potential to reduce diabetes related blindness.
Published: Jun 14, 2016 1:02:15 PM
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London.
Published: Jun 10, 2016 4:18:28 PM